Elsevier Launches JACC: Basic to Translational Science

A new open access publication joins the family of focused JACC journals


New York, NY, March 16, 2016

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, is pleased to announce publication of the inaugural issue of JACC: Basic to Translational Science, a new open access peer-reviewed journal. Published on behalf of the American College of Cardiology (ACC), this new bi-monthly journal focuses on the critical interface between laboratory and clinical science.

Led by Editor-in-Chief Douglas L. Mann, MD, FACC, and an eminent editorial board, JACC: Basic to Translational Science is designed to be both a forum and a learning center for cardiovascular investigators in academia and industry, patients and families impacted by heart disease, the National Heart Blood and Lung Institute and the US Food and Drug Administration to help advance translational cardiovascular medicine. It serves as a platform for accelerating the translation of new scientific discoveries into new therapies that improve clinical outcomes for patients afflicted with or at risk for cardiovascular disease.

“We find two compelling reasons to launch this journal in collaboration with Elsevier and ACC. The first is to create a true scientific literary home for cardiovascular ‘translationalists’ who wish to publish research that stands firmly at the crossroads of basic and clinical research, that presents new ideas and potentially leads to new therapies,” explained Dr. Mann. “The second, and perhaps more compelling, is the unprecedented opportunity today to develop novel cardiovascular drugs and devices. The explosion of ‘omic’ technologies, bioinformatics, in silico structure modeling, high throughput screening, and novel clinical designs, and the willingness of Congress to advance new clinical therapies have converged to offer an extremely opportune time for investigators to focus their efforts on developing new cardiovascular therapies.”

Manuscripts are currently being accepted at www.jaccsubmit-basicts.org. Thematic areas of interest include pre-clinical research; clinical trials; personalized medicine; novel drugs, devices and biologics; proteomics, genomics and metabolomics; and early-phase clinical trial methodology.

“It is extremely gratifying to have the opportunity to launch such a high quality and precisely targeted journal. We recognize the vital role that JACC: Basic to Translational Science publication will play in facilitating the translation of research initiatives in cardiovascular medicine, with the potential to lead to truly groundbreaking advancements in patient care,” commented Nancy Axelrod, Executive Publisher at Elsevier. “As publishers of ACC’s official journals for more than 30 years, including the Journal of the American College of Cardiology, we are confident of its success.”

---

About the Journal of the American College of Cardiology
The Journal of the American College of Cardiology, which publishes peer-reviewed research on all aspects of cardiovascular disease, is the most widely read cardiovascular journal worldwide. JACC is ranked No. 1 among cardiovascular journals worldwide for its scientific impact.

About the American College of Cardiology
The American College of Cardiologyis a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care. It also provides professional medical education, offers cardiovascular accreditation to hospitals and institutions, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.

About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 500 open access journals and these numbers will continue to grow rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research, but that it is factual, original, and of the highest quality and ethical standards. For more information about Elsevier’s open access program, visit www.elsevier.com/openaccess

About Elsevier
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Media contact
Nancy Axelrod
Executive Publisher
Elsevier
+1 212 633 3958
n.axelrod@elsevier.com